Literature DB >> 19461922

Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.

Gary Y Yang1, Susan A McClosky, Nikhil I Khushalani.   

Abstract

Esophageal cancer is a highly virulent neoplasm with high morbidity and mortality. With the benefit of radiotherapy (RT) combined with chemotherapy clearly established, the challenge is in the accurate and safe delivery of radiotherapy. Improved understanding of patterns of esophageal cancer relapse and tumor spread and of organ motion in the upper thorax and abdomen have allowed for implementation of more conformal radiation techniques, including respiratory-gated RT, imageguided RT (IGRT), and intensity-modulated RT (IMRT). At a minimum, successful implementation of conformal radiation delivery requires a detailed understanding of esophageal anatomy and radiobiological principles, an individualized assessment of organ motion, precise patient immobilization techniques, and adequate physics and dosimetry expertise. To aid the practicing clinician, the National Comprehensive Cancer Network (NCCN) has recently incorporated detailed recommendations on simulation, treatment planning, target volumes, and dose limits for select critical normal structures. The practicing clinician is urged to utilize the multitude of resources now available to ensure that optimal adjuvant radiotherapy for esophageal cancer is delivered safely and accurately.

Entities:  

Year:  2009        PMID: 19461922      PMCID: PMC2684733     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


  44 in total

1.  Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.

Authors:  Vinai Gondi; Kristin Bradley; Minesh Mehta; Andy Howard; Deepak Khuntia; Mark Ritter; Wolfgang Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-01       Impact factor: 7.038

2.  Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

Authors:  Laurence Moureau-Zabotto; Emmanuel Touboul; Delphine Lerouge; Elisabeth Deniaud-Alexandre; Dany Grahek; Jean-Noël Foulquier; Yolande Petegnief; Benoît Grès; Hanna El Balaa; Kaldoun Kerrou; Françoise Montravers; Katia Keraudy; Emmanuel Tiret; Jean-Pierre Gendre; Jean-Didier Grange; Sidney Houry; Jean-Noël Talbot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

3.  Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?

Authors:  Olga Vrieze; Karin Haustermans; Walter De Wever; Toni Lerut; Eric Van Cutsem; Nadine Ectors; Martin Hiele; Patrick Flamen
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

4.  Coronary heart disease after radiotherapy for peptic ulcer disease.

Authors:  Zhanat A Carr; Charles E Land; Ruth A Kleinerman; Robert W Weinstock; Marilyn Stovall; Melvin L Griem; Kiyohiko Mabuchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

5.  Coronary artery disease mortality in patients treated for Hodgkin's disease.

Authors:  J F Boivin; G B Hutchison; J H Lubin; P Mauch
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

6.  Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.

Authors:  Yi-Jen Chen; An Liu; Chunhui Han; Peter T Tsai; Timothy E Schultheiss; Richard D Pezner; Nilesh Vora; Dean Lim; Stephen Shibata; Kemp H Kernstine; Jeffrey Y C Wong
Journal:  Med Dosim       Date:  2007       Impact factor: 1.482

7.  Setup variations in radiotherapy of esophageal cancer: evaluation by daily megavoltage computed tomographic localization.

Authors:  Yi-Jen Chen; Chunhui Han; An Liu; Timothy E Schultheiss; Kemp H Kernstine; Stephen Shibata; Nayana L Vora; Richard D Pezner; Jeffrey Y C Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-25       Impact factor: 7.038

Review 8.  Cardiac mortality and morbidity after breast cancer treatment.

Authors:  Eleanor E Harris
Journal:  Cancer Control       Date:  2008-04       Impact factor: 3.302

9.  Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.

Authors:  S L Kwa; J C Theuws; A Wagenaar; E M Damen; L J Boersma; P Baas; S H Muller; J V Lebesque
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280

10.  Hybrid IMRT for treatment of cancers of the lung and esophagus.

Authors:  Charles S Mayo; Marcia M Urie; Thomas J Fitzgerald; Linda Ding; Yuan Chyuan Lo; Madeleine Bogdanov
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-11       Impact factor: 7.038

View more
  5 in total

Review 1.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

2.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

3.  Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.

Authors:  Guanzhong Gong; Ruozheng Wang; Yujie Guo; Deyin Zhai; Tonghai Liu; Jie Lu; Jinhu Chen; Chengxin Liu; Yong Yin
Journal:  Radiat Oncol       Date:  2013-12-20       Impact factor: 3.481

4.  Characterization of Respiration-Induced Motion in Prone Versus Supine Patient Positioning for Thoracic Radiation Therapy.

Authors:  Christopher L Guy; Elisabeth Weiss; Mihaela Rosu-Bubulac
Journal:  Adv Radiat Oncol       Date:  2020-02-28

5.  Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients.

Authors:  Ted C Ling; Jerry M Slater; Prashanth Nookala; Rachel Mifflin; Roger Grove; Anh M Ly; Baldev Patyal; Jerry D Slater; Gary Y Yang
Journal:  Cancers (Basel)       Date:  2014-12-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.